apixaban pinewood 5 mg film-coated tablets
pinewood laboratories ltd - apixaban - film-coated tablet - apixaban
apixaban 2.5 mg film-coated tablets
renata pharmaceuticals (ireland) limited - apixaban - film-coated tablet - apixaban
apixaban 5 mg film-coated tablets
renata pharmaceuticals (ireland) limited - apixaban - film-coated tablet - apixaban
m-apixaban tablet
mantra pharma inc - apixaban - tablet - 2.5mg - apixaban 2.5mg
m-apixaban tablet
mantra pharma inc - apixaban - tablet - 5mg - apixaban 5mg
taro-apixaban tablet
sun pharma canada inc - apixaban - tablet - 2.5mg - apixaban 2.5mg
taro-apixaban tablet
sun pharma canada inc - apixaban - tablet - 5mg - apixaban 5mg
teva-apixaban tablet
teva canada limited - apixaban - tablet - 2.5mg - apixaban 2.5mg
teva-apixaban tablet
teva canada limited - apixaban - tablet - 5mg - apixaban 5mg
apixaban accord
accord healthcare s.l.u. - apixaban - venous thromboembolism; stroke; arthroplasty - antithrombotic agents - prevention of venous thromboembolic events (vte) in adult patients who have undergone elective hip or knee replacement surgery.prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age ≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ≥ ii).treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults (see section 4.4 for haemodynamically unstable pe patients).prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (nvaf), with one or more risk factors, such as prior stroke or transient ischaemic attack (tia); age≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (nyha class ≥ ii).treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults (see section 4.4 for haemodynamically unstable pe patients).